The first fully AI-generated medicines enter human clinical trials
Clinical trials of the first medicines created entirely by artificial intelligence have begun in China. Hong Kong-based biotechnology startup Insilico Medicine has developed INS018_055 for the treatment of idiopathic pulmonary fibrosis (IPF). It is a chronic disease that causes scarring in the lungs. Every year, about 100,000 people in the United States are diagnosed with […]